PTGS2 and Cognitive impairment: In lipopolysaccharide (LPS)-induced rats, Rg3 administration significantly alleviates cognitive impairment by inhibiting the expression of pro-inflammatory mediators (TNF-α, IL-1β, and cyclooxygenase 2 [COX-2]) in the brain (Lee et al., 2013).